UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (1), p.158-166

2020

Link zum Volltext

Verfügbarkeit prüfen

One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (4), p.462-469

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry

Hepatology (Baltimore, Md.), 2017-06, Vol.65 (6), p.1810-1822

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection

PloS one, 2018-03, Vol.13 (3), p.e0193829-e0193829

2018

Link zum Volltext

Verfügbarkeit prüfen

Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review

Scientific reports, 2021-12, Vol.11 (1), p.24133-24133, Article 24133

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1702-1708

2009

Link zum Volltext

Verfügbarkeit prüfen

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

PloS one, 2017-03, Vol.12 (3), p.e0173943-e0173943

2017

Link zum Volltext

Verfügbarkeit prüfen

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

Viruses, 2023-07, Vol.15 (7), p.1506

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

Frontiers in cellular and infection microbiology, 2023-03, Vol.13, p.1057082-1057082

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

Journal of hepatology, 2020-11, Vol.73 (5), p.1262-1263

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease

European journal of clinical investigation, 2014-01, Vol.44 (1), p.65-73

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype

World journal of gastroenterology : WJG, 2016-03, Vol.22 (11), p.3165-3174

Antonio Madejón Míriam Romero ángela Hernández Araceli García-Sánchez Marta Sánchez-Carrillo Antonio Olveira Javier García-Samaniego

2016

Link zum Volltext

Verfügbarkeit prüfen

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

Communications medicine, 2022-02, Vol.2 (1), p.20-20, Article 20

2022

Link zum Volltext

Verfügbarkeit prüfen

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

Journal of hepatology, 2021-07, Vol.75 (1), p.224-226

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results

Revista española de enfermedades digestivas, 2020-07, Vol.112 (7), p.532-537

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality of life study in asymptomatic patients with hepatitis C

Revista española de enfermedades digestivas, 2020-07, Vol.112 (7), p.520-524

2020

Link zum Volltext

Verfügbarkeit prüfen

Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19

The Journal of infectious diseases, 2020-08, Vol.222 (5), p.726-733

2020

Link zum Volltext

Verfügbarkeit prüfen

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1397-1401

2009

Link zum Volltext

Verfügbarkeit prüfen

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

European journal of clinical investigation, 2011-01, Vol.41 (1), p.70-76

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of occult hepatitis B virus infection

World journal of gastroenterology : WJG, 2011-03, Vol.17 (12), p.1549-1552

Romero, Miriam

2011

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Journal of hepatology, 2019-10, Vol.71 (4), p.666-672

2019

Link zum Volltext

Verfügbarkeit prüfen

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Alimentary pharmacology & therapeutics, 2018-12, Vol.48 (11-12), p.1260-1270

2018

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Clinical gastroenterology and hepatology, 2009-03, Vol.7 (3), p.339-345

2009

Link zum Volltext

Verfügbarkeit prüfen

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Journal of acquired immune deficiency syndromes (1999), 2005-08, Vol.39 (4), p.401

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(216)

Publikationsform

Artikel
(240)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(132)
Humans
(126)
Male
(78)
Adult
(75)
Female
(71)
Infectious Diseases
(70)
Gastroenterology & Hepatology
(65)
Antiviral Agents - Therapeutic Use
(64)
Hepatitis C
(55)
Middle Aged
(54)
Hiv Infections - Complications
(48)
Hepatitis C Virus
(45)
Hepatitis C, Chronic - Drug Therapy
(45)
Biological And Medical Sciences
(44)
Medical Sciences
(44)
Human Immunodeficiency Virus
(41)
Hiv
(40)
Virology
(39)
Genotype
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection

Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease

Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results

Quality of life study in asymptomatic patients with hepatitis C

Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

Clinical significance of occult hepatitis B virus infection

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Suchergebnisse filtern